James A. Baber

38-42 Wharf Rd
West Ryde, NSW 2114, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial: Correction.

Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial: Correction.

Journal: Obstetrics and gynecology

Published: July 16, 2026

Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial.

Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial.

Journal: Obstetrics and gynecology

Published: September 17, 2024

Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial.

Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial.

Journal: Vaccine

Published: March 21, 2024

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults.

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: August 31, 2023

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults.

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults.

Journal: Infectious diseases and therapy

Published: July 10, 2023

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.

Journal: The New England journal of medicine

Published: April 05, 2023

Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial.

Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: November 02, 2022

A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults.

A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults.

Journal: The Journal of infectious diseases

Published: December 20, 2021

A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.

A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.

Journal: Nature communications

Published: August 02, 2021

Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag).

Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag).

Journal: Open forum infectious diseases

Published: October 31, 2019

S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine.

S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine.

Journal: The Journal of infection

Published: May 23, 2019

The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery.

The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery.

Journal: Human vaccines & immunotherapeutics

Published: September 15, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026